Skip to main content

Table 1 Drugs under investigation for CSU

From: Looking forward to new targeted treatments for chronic spontaneous urticaria

Study drug Type of the drug identifier Status
Quilizumab Anti-IgE NCT01987947 Completed
Ligelizumab Anti-IgE NCT02477332 Recruitment closed
AZD1981 PGD2 receptor antagonists NCT02031679 Data processing
GSK2646264 Syk inhibitor NCT02424799 Recruiting
Canakinumab Anti-IL-1 NCT01635127 Unknown
Rilonacept Anti-IL-1 NCT02171416 Recruiting
  1. Syk spleen tyrosine kinase, PGD2 prostagladin D2, IL-1 ınterleukin-1